Edition:
United Kingdom

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

56.07USD
14 Nov 2018
Change (% chg)

-- (--)
Prev Close
$56.07
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
32,559
52-wk High
$76.98
52-wk Low
$34.40

Chart for

About

Ascendis Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in applying its TransCon technology to develop sustained release prodrug therapies with several product candidates in clinical and preclinical development. The Company is developing its product candidate, TransCon human growth hormone... (more)

Overall

Beta: --
Market Cap(Mil.): $1,304.09
Shares Outstanding(Mil.): 36.37
Dividend: --
Yield (%): --

Financials

  ASND.OQ Industry Sector
P/E (TTM): -- 85.49 33.64
EPS (TTM): -3.50 -- --
ROI: -83.31 -0.29 14.22
ROE: -83.31 0.40 15.99

Earnings vs. Estimates